At a glance
ClinicalIndex Comparison RecordN/ACompleted· 68 enrolled
Drug / intervention
Cranial Electrostimulator +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches
In Brief
A clinical study evaluating Cranial Electrostimulator and Sham Device for Migraine. Completed, enrolled 68 participants across 1 site.
Detailed Summary
Cranial electrotherapy stimulation (CES) may be a safe adjunct to medical treatment for pain relief in migraine patients. However, despite the number of CES studies done, many have been open label, single blinded, or have utilized a small group of patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 2010
Enrollment StartDec 2011
Primary CompletionFeb 2013
Study CompletionJul 2013
TodayJul 2026
First PostedDec 23, 2010
Enrollment StartDec 1, 2011
Primary CompletionFeb 1, 2013
Study CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.5 years ago
Interventions
Cranial Electrostimulatordevice
participant wears active cranial electrostimulation device for 20 minutes daily for 28 days
Sham Devicedevice
participant wears sham device for 20 minutes daily for 28 days